Clinical trial
Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to…
NCT00402337 · Ironwood Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00402337 |
|---|---|
| Title | Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation |
| Official title | A Randomized, Multicenter, Double-blind, Placebo-controlled, Dose-range-finding, Parallel-group, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation |
| Lead sponsor | Ironwood Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Constipation |
| Intervention type | Drug |
| Interventions | linaclotide acetate, Matching placebo |
| Enrollment | 310 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Nov 22, 2006 |
| Last update posted | Mar 5, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: